eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2006, Volume 2, Issue 1 : 109-114 doi: ijmmas.2006.109.114
Research Article
Aberrant Neurofilament Trafficking and Membrane-Anchored Proteolytic Events Constituting Transformation Of Senile Brain Atrophy to An Alzheimer Disease Process
Published
Sept. 30, 2005
Abstract

A self-progressive neurodegenerative event of Alzheimer type would involve a distinctive process of increasing membrane proteolysis as the cause of neuronal cell death and of various aberrant attempts at dystrophic recovery.  Indeed, a conceptual distinction of the Alzheimer process from senile brain atrophy might arise as a strict phenomenon of evolving protein-protein interactions and of various aberrant patterns of intracellular protein trafficking that mark out the Alzheimer neurodegenerative event as paradoxically both constitutional and possibly also of acquired nature.  In terms, indeed, of a progressive phenomenon of atrophy of the brain that is neuronal in specific pathogenesis but also arising inherently as a neurodegenerative series of aberrant pathway attempts at recovery of injured neurons, a single event of degeneration would arise from proteolytic involvement of the neuronal cell body. It is in terms of such a postulated integral event of self-progressive proteolysis arising and evolving within neuronal membranes that there would be implicated not only ApoE isoforms but also Presenilin-1 and –2 as membrane-anchored molecules of progression in the Alzheimer process. Indeed, an integral neurodegenerative event of neuronal membrane processing would arise and proceed as a series of synaptic and neuritic dystrophic forms of activity specifically distinguishing the disorder from simple senile brain atrophy.  It is perhaps in terms of quantitatively significant degrees of increased neuronal cell loss that Alzheimer disease would indeed constitute an active participation of various membrane-based transformations ranging from ubiquination to proteolysis to protein-protein interaction and lipid metabolism to Ca2 + /K + channeling as one constitutive Alzheimer process with added acquired dimensions.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Smart Hospitals and Healthcare Automation: Transforming Healthcare Delivery Through Artificial Intelligence, Internet of Medical Things, and Intelligent Automation
16-20
Predictors of Acute Coronary Syndrome Outcomes: A Multicenter Evaluation of Clinical, Biochemical, and Demographic Risk Factors
11-15
PCI Outcomes in Patients With Chronic Total Occlusion
14-17
Impact of Dual Antiplatelet Therapy Duration on Post-PCI Outcomes
11-14
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.